BSR guidelines for TNF blockers in ankylosing spondylitis--how useful are they?
Sheehy
C
C
Murphy
E
E
Barry
M
M
D019983:Guideline Adherence; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D018579:Patient Selection; D017410:Practice Guidelines as Topic; D013167:Spondylitis, Ankylosing / Q000175:diagnosis / Q000188:drug therapy*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D007166:Immunosuppressive Agents; D014409:Tumor Necrosis Factor-alpha